Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Vaughan
The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Recipients of Oocyte Donation Have Higher Rates of Gestational Hypertensive Disease Than Those Conceived via Autologous in Vitro Fertilization (IVF)
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
Related publications
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
The Long Non-Coding RNA MYCNOS-01 Regulates MYCN Protein Levels and Affects Growth of MYCN-amplified Rhabdomyosarcoma and Neuroblastoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Epigenetic Regulation of the Neuroblastoma Genes, Arid3b and Mycn
Oncogene
Cancer Research
Genetics
Molecular Biology
ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma
Frontiers in Oncology
Cancer Research
Oncology
Burkholderia Lethal Factor 1, a Novel Anti-Cancer Toxin, Demonstrates Selective Cytotoxicity in MYCN-Amplified Neuroblastoma Cells
Toxins
Mutagenesis
Toxicology
Health
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Cancer Cell
Cancer Research
Oncology
Cell Biology
P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Cancer Research
Cancer Research
Oncology